You are here: Home » Markets » News

Sensex ends 110 pts lower ahead of Q2 GDP data; BSE Smallcap index up 2.4%

All that happened in the markets today

Markets | Sensex | Nifty 50

SI Reporter  | New Delhi 


The benchmark indices ended Friday's volatile session in the negative territory ahead of the release of gross domestic product (GDP) numbers for the second quarter (July-September period) of the current fiscal, due later in the day. 

The S&P BSE slipped 110 points, or 0.25 per cent to 44,150 levels and the Nifty50 index ended at 12,969, down 18 points, or 0.14 per cent. Power Grid, HCL Tech, and ONGC (all down around 2 per cent) were the top laggards. 

On a weekly basis, gained 0.6 per cent while Nifty added 0.85 per cent. 

The broader market, however, outperformed the benchmark indices today. While the S&P BSE MidCap index surged 1.91 per cent to 16,915, the S&P BSE SmallCap index rallied an impressive 2.4 per cent to 16,875 levels. 

Among sectoral indices, barring Nifty IT, all other indices ended in the green. Nifty Auto gained 1.41 per cent while Nifty Realty surged 2.65 per cent. 

Shares of gas transmission companies rallied up to 19 per cent on the BSE during the day after oil regulator Petroleum and Natural Gas Regulatory Board (PNGRB) notified regulations for unified gas transmission tariff structure. READ MORE

The domestic equity and currency will remain shut on Monday, November 30, on account of Gurunanak Jayanti.

Global stocks

Asian shares stalled near record highs on Friday as investors weighed renewed doubts about a highly-anticipated coronavirus vaccine against hopes that some of the region’s economies will recovery quicker than their Western peers.

MSCI’s broadest index of Asia-Pacific shares outside Japan dipped 0.04 per cent. Japan’s Nikkei rose 0.33 per cent while shares in China rose 0.13 per cent after data showed Chinese industrial profits surged at the fastest pace since early 2017.

In commodities, oil prices traded lower in quiet trade due to the US Thanksgiving holiday, dropping amid concerns about oversupply and doubts about a vaccine to end the coronavirus pandemic.

(With inputs from Reuters)


Auto Refresh